Stay updated on Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial
Sign up to get notified when there's something new on the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page.

Latest updates to the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page
- Check2 days agoChange DetectedThe NIH banner announcing a transition from “Artificial Intelligence” to “Super Intelligence” terminology, along with related update and FAQ information, is no longer displayed.SummaryDifference1%

- Check9 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA site-wide NIH banner announces a website transition and says agencies are using “Super Intelligence” in place of “Artificial Intelligence.” The displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check37 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden message.SummaryDifference0.2%

- Check51 days agoChange DetectedA large block of indexing terms and related metadata was removed from the study record, reducing the searchable keywords and references shown alongside the main trial details.SummaryDifference17%

- Check58 days agoChange DetectedThe page's revision label was updated from v3.6.6 to v3.7.0, indicating a new version of the page or its underlying tooling.SummaryDifference0.0%

Stay in the know with updates to Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page.